drugset / Trial / NCT03015701
S9005 Mifepristone in Meningioma
Phase 3
Completed
193 enrolled
SWOG Cancer Research Network
National Cancer Institute (NCI) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To compare daily oral mifepristone vs placebo with respect to time to treatment failure in patients with unresectable meningioma.
Timeline
- Start
- 1992-08
- Primary completion
- 2001-10
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mifepristone | Small molecule | 200 mg | Oral |